ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,106,661 | -10.1% | 7,571,693 | -7.4% | 0.03% | -9.7% |
| Q2 2023 | $30,161,385 | +11.0% | 8,173,817 | -0.5% | 0.03% | +6.9% |
| Q1 2023 | $27,180,306 | -17.7% | 8,211,573 | -3.5% | 0.03% | -19.4% |
| Q4 2022 | $33,012,627 | +132.5% | 8,508,409 | +45.6% | 0.04% | +111.8% |
| Q3 2022 | $14,201,000 | +48.4% | 5,843,796 | +20.9% | 0.02% | +54.5% |
| Q2 2022 | $9,568,000 | +174.8% | 4,832,392 | +154.0% | 0.01% | +266.7% |
| Q1 2022 | $3,482,000 | +2663.5% | 1,902,288 | +2030.1% | 0.00% | – |
| Q4 2021 | $126,000 | -62.8% | 89,307 | -57.8% | 0.00% | – |
| Q2 2021 | $339,000 | +1312.5% | 211,692 | +2010.6% | 0.00% | – |
| Q3 2020 | $24,000 | – | 10,030 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |